We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Study Shows Zika Virus Persists in Body Fluids

By LabMedica International staff writers
Posted on 18 Oct 2018
Print article
Image: The GenoAmp Trioplex Real-Time RT-PCR Zika/Den/Chiku kit is a real-time molecular diagnostic test for the screening and differentiation of Zika, dengue and chikungunya virus, extracted from human plasma/serum (Photo courtesy of Mediven).
Image: The GenoAmp Trioplex Real-Time RT-PCR Zika/Den/Chiku kit is a real-time molecular diagnostic test for the screening and differentiation of Zika, dengue and chikungunya virus, extracted from human plasma/serum (Photo courtesy of Mediven).
Although most Zika virus (ZIKV) infections are transmitted by infected mosquitoes, ZIKV transmission has been documented as occurring through sexual contact, blood transfusion, laboratory exposure, and both intrauterine and intrapartum transmission.

ZIKV infection can be diagnosed through detection of ZIKV RNA in blood, urine, and other body fluids by reverse-transcriptase–polymerase-chain-reaction (RT-PCR) assays. However, the frequency with which ZIKV RNA can be detected in various body fluids and the length of time that it remains detectable are not well understood.

An international team of scientists cooperating with the Centers for Disease Control and Prevention (CDC, Atlanta, GA, USA) evaluated samples obtained from 295 participants (including 94 men who provided semen specimens) in whom ZIKV RNA was detected on RT-PCR assay in urine or blood at an enhanced arboviral clinical surveillance site. The study was based on 295 people in Puerto Rico infected with Zika beginning in May 2016. The team collected samples of serum, urine, saliva, semen, and vaginal secretions weekly for the first month and at 2, 4, and 6 months after diagnosis. The mean age of the participants was 36 years; 51% were female, including nine who were pregnant.

Specimens, measuring 200 μL, were tested by means of the Trioplex RT-PCR assay, as recommended by the CDC for the detection of dengue, chikungunya, and ZIKV RNA. In addition, they performed validation analyses for the use of the Trioplex RT-PCR assay in semen. Serum was tested by means of anti–ZIKV IgM antibody capture enzyme-linked immunosorbent assay. ZIKV isolation was attempted through culture in a subset of semen and serum specimens.

The investigators reported that the median and 95th percentile for the time until the loss of Zika RNA detection were 15 days, and 41 days respectively, in serum; 11 days, and 34 days in urine; and 42 days and 120 days in semen. Less than 5% of participants had detectable Zika RNA in saliva or vaginal secretions. Compared with preliminary findings, the median time of RNA clearance in semen rose from 34 to 42 days, and for 95th percentile it climbed from 81 to 120 days.

The authors concluded that the prolonged time until ZIKV RNA clearance in serum in this study may have implications for the diagnosis and prevention of ZIKV infection. In 95% of the men in this study, ZIKV RNA was cleared from semen after approximately four months.

Gabriela Paz-Bailey, MD, PhD, the lead author of the study, said, “Anyone concerned about getting or passing Zika through sex should use condoms every time they have sex or not have sex for at least three months after symptom onset to allow Zika virus to clear from semen. Because Zika infection during pregnancy can cause severe birth defects, pregnant women should not travel to areas with Zika transmission risk. All travelers should strictly follow steps to prevent mosquito bites and prevent sexual transmission during and after the trip.” The study was published on September 27, 2018, in The New England Journal of Medicine.

Related Links:
Centers for Disease Control and Prevention

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.